Beta Bionics (BBNX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $16.35, -5.55% vs the prior close of $17.31.
- Volume 660.83K shares, 0.5x its 50-day average (light).
- New SEC filings: 4 (Oct 16, 2026).
- No new insider buys or sales reported since the prior session.
BBNX slides 5.5% to $16.35, a 1-month low. Closed at $16.35, -5.55% vs the prior close of $17.31. Day range $16.32–$17.53, opened at $17.42.
BBNX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — BBNX slides 5.5% to $16.35, a 1-month low
- Closed at $16.35, -5.55% vs the prior close of $17.31. Day range $16.32–$17.53, opened at $17.42.
- Volume was 660.83K shares, 0.5x its 50-day average of 1.22M — lighter than usual.
- Price is -13.8% vs its 50-day average ($18.97) and +7.8% vs its 200-day average ($15.17).
- 52-week range $8.80–$32.71; today's close sits at 32% of that range, 50.0% below the 52-week high.
Oct 15, 2026 — BBNX rises 2.6% to $17.31
- Closed at $17.31, +2.61% vs the prior close of $16.87. Day range $16.60–$17.60, opened at $16.98.
- Volume was 1.33M shares, 1.1x its 50-day average of 1.21M.
- Price is -8.6% vs its 50-day average ($18.93) and +13.5% vs its 200-day average ($15.25).
- 52-week range $8.80–$32.71; today's close sits at 36% of that range, 47.1% below the 52-week high.
Oct 14, 2026 — BBNX slides 4.6% to $16.87, a 1-month low
- Closed at $16.87, -4.64% vs the prior close of $17.69. Day range $16.72–$17.54, opened at $17.35.
- Volume was 892.90K shares, 0.7x its 50-day average of 1.26M.
- Price is -10.6% vs its 50-day average ($18.86) and +10.1% vs its 200-day average ($15.32).
- 52-week range $8.80–$32.71; today's close sits at 34% of that range, 48.4% below the 52-week high.
Oct 13, 2026 — BBNX dips 1.0% to $17.69
- Closed at $17.69, -0.95% vs the prior close of $17.86. Day range $17.52–$18.14, opened at $17.87.
- Volume was 591.20K shares, 0.5x its 50-day average of 1.30M — lighter than usual.
- Price is -6.0% vs its 50-day average ($18.81) and +14.9% vs its 200-day average ($15.39).
- 52-week range $8.80–$32.71; today's close sits at 37% of that range, 45.9% below the 52-week high.
Oct 12, 2026 — BBNX rises 1.3% to $17.86
- Closed at $17.86, +1.30% vs the prior close of $17.63. Day range $17.71–$18.56, opened at $17.94.
- Volume was 820.70K shares, 0.6x its 50-day average of 1.32M.
- Price is -4.6% vs its 50-day average ($18.73) and +15.5% vs its 200-day average ($15.46).
- 52-week range $8.80–$32.71; today's close sits at 38% of that range, 45.4% below the 52-week high.
Oct 9, 2026 — BBNX rises 1.1% to $17.63
- Closed at $17.63, +1.15% vs the prior close of $17.43. Day range $17.12–$17.88, opened at $17.47.
- Volume was 955.10K shares, 0.7x its 50-day average of 1.37M.
- Price is -5.4% vs its 50-day average ($18.63) and +13.5% vs its 200-day average ($15.53).
- 52-week range $8.80–$32.71; today's close sits at 37% of that range, 46.1% below the 52-week high.
Oct 8, 2026 — BBNX slides 3.6% to $17.43, 4 down days in a row
- Closed at $17.43, -3.60% vs the prior close of $18.08. Day range $17.07–$18.04, opened at $17.96.
- Volume was 1.11M shares, 0.8x its 50-day average of 1.38M.
- Price is -6.1% vs its 50-day average ($18.56) and +11.7% vs its 200-day average ($15.60).
- 52-week range $8.80–$32.71; today's close sits at 36% of that range, 46.7% below the 52-week high.
- That makes 4 straight losses.
Oct 7, 2026 — BBNX dips 3.0% to $18.08, 3 down days in a row
- Closed at $18.08, -2.95% vs the prior close of $18.63. Day range $17.93–$19.11, opened at $18.91.
- Volume was 1.53M shares, 1.1x its 50-day average of 1.36M.
- Price is -2.3% vs its 50-day average ($18.52) and +15.5% vs its 200-day average ($15.66).
- 52-week range $8.80–$32.71; today's close sits at 39% of that range, 44.7% below the 52-week high.
- That makes 3 straight losses.
Oct 6, 2026 — BBNX dips 1.7% to $18.63
- Closed at $18.63, -1.69% vs the prior close of $18.95. Day range $18.31–$19.24, opened at $18.91.
- Volume was 922.80K shares, 0.7x its 50-day average of 1.36M.
- Price is +0.9% vs its 50-day average ($18.47) and +18.6% vs its 200-day average ($15.71).
- 52-week range $8.80–$32.71; today's close sits at 41% of that range, 43.0% below the 52-week high.
Oct 5, 2026 — BBNX ends flat (-0.1%) to $18.95
- Closed at $18.95, -0.05% vs the prior close of $18.96. Day range $18.74–$19.26, opened at $18.91.
- Volume was 624.60K shares, 0.5x its 50-day average of 1.36M — lighter than usual.
- Price is +2.9% vs its 50-day average ($18.42) and +20.2% vs its 200-day average ($15.77).
- 52-week range $8.80–$32.71; today's close sits at 42% of that range, 42.1% below the 52-week high.
Oct 2, 2026 — BBNX rises 0.5% to $18.96
- Closed at $18.96, +0.48% vs the prior close of $18.87. Day range $18.27–$19.26, opened at $18.87.
- Volume was 515.10K shares, 0.4x its 50-day average of 1.38M — lighter than usual.
- Price is +3.3% vs its 50-day average ($18.35) and +19.9% vs its 200-day average ($15.82).
- 52-week range $8.80–$32.71; today's close sits at 42% of that range, 42.0% below the 52-week high.
BBNX latest news & SEC filings
Every SEC filing by or about BBNX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Hopman Mark sold 775 shares at $17.35 (≈$13.45K) on Oct 14, 2026; now holds 55,334
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 7, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Hopman Mark sold 370 shares at $18.96 (≈$7.02K) on Oct 1, 2026; now holds 56,109
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 23, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Jones Christy sold 6,430 shares at $23.00 (≈$147.89K) on Sep 22, 2026; now holds 19,564
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 22, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 18, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
- Hopman Mark sold 35,994 shares at $18.46 (≈$664.55K) on Sep 9, 2026; now holds 88,033
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 17, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 16, 2026 · Form FWP — Free writing prospectus (offering marketing material)
Free writing prospectus (offering marketing material)
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 16, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 29, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $32.01M (prior year $23.24M) (+37.8% vs Jun 30, 2025)
- Net income: -$23.40M (prior year -$16.87M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.53 (prior year -$0.39) (loss widened vs Jun 30, 2025)
Jul 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade BBNX
- Last results release: Jul 29, 2026 (8-K Item 2.02). Previous ones: Apr 21, 2026, Feb 17, 2026, Jan 8, 2026. Based on that rhythm, the next report is likely around Oct 28, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.39% (largest 5.5%).
- Liquidity: about 1.01M shares (≈$16.49M) trade per day on average.
- 52-week position: $16.35 vs a range of $8.80–$32.71 (32% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Christy Jones sold 6,430 shares on Sep 22, 2026.
- Latest filings: 8-K Sep 17, 2026; 8-K Sep 15, 2026; 10-Q Jul 29, 2026.
- Share count: 44.99M shares outstanding (Jul 27, 2026), +3.5% vs a year earlier.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
BBNX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 17.42 | 17.53 | 16.32 | 16.35 | 660.83K |
| Oct 15, 2026 | 16.98 | 17.60 | 16.60 | 17.31 | 1.33M |
| Oct 14, 2026 | 17.35 | 17.54 | 16.72 | 16.87 | 892.90K |
| Oct 13, 2026 | 17.87 | 18.14 | 17.52 | 17.69 | 591.20K |
| Oct 12, 2026 | 17.94 | 18.56 | 17.71 | 17.86 | 820.70K |
| Oct 9, 2026 | 17.47 | 17.88 | 17.12 | 17.63 | 955.10K |
| Oct 8, 2026 | 17.96 | 18.04 | 17.07 | 17.43 | 1.11M |
| Oct 7, 2026 | 18.91 | 19.11 | 17.93 | 18.08 | 1.53M |
| Oct 6, 2026 | 18.91 | 19.24 | 18.31 | 18.63 | 922.80K |
| Oct 5, 2026 | 18.91 | 19.26 | 18.74 | 18.95 | 624.60K |
| Oct 2, 2026 | 18.87 | 19.26 | 18.27 | 18.96 | 515.10K |
| Oct 1, 2026 | 19.35 | 19.44 | 18.39 | 18.87 | 1.14M |
| Sep 30, 2026 | 19.22 | 19.52 | 18.45 | 18.98 | 1.46M |
| Sep 29, 2026 | 20.61 | 20.73 | 19.28 | 19.41 | 842.50K |
| Sep 28, 2026 | 21.50 | 21.69 | 19.93 | 20.52 | 1.76M |
| Sep 25, 2026 | 21.74 | 21.98 | 21.25 | 21.51 | 926.00K |
| Sep 24, 2026 | 22.31 | 22.62 | 21.44 | 21.76 | 906.80K |
| Sep 23, 2026 | 23.00 | 23.48 | 21.88 | 22.19 | 1.40M |
| Sep 22, 2026 | 22.18 | 23.56 | 22.10 | 22.81 | 999.60K |
| Sep 21, 2026 | 22.11 | 22.48 | 21.78 | 22.04 | 783.30K |
About Beta Bionics
Beta Bionics (BBNX) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in IRVINE, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1674632.
BBNX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Sean Carney | Director | May 26, 2026 |
| Danny L. Dearen | Director | May 26, 2026 |
| Christy Jones | Director | Sep 23, 2026 |
| Adam Lezack | Director | May 26, 2026 |
| Gerard J Michel | Director | May 26, 2026 |
| Maria Palasis | Director | May 26, 2026 |
| Sean Saint | President & CEO | Sep 4, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Stephen Feider | Chief Financial Officer | Sep 3, 2026 |
| Mark Hopman | Chief Commercial Officer | Sep 18, 2026 |
| Mike Mensinger | Chief Product Officer | Sep 17, 2026 |
| Steven Jon Russell | Chief Medical Officer | Sep 3, 2026 |
| Sean Saint | President & CEO | Sep 4, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 22, 2026 | Christy Jones | Sale | 6,430 | $23.00 |
| Sep 22, 2026 | Christy Jones | Sale | 6,430 | $23.00 |
| Sep 22, 2026 | Christy Jones | Sale | 6,430 | $23.00 |
| Sep 22, 2026 | Christy Jones | Sale | 6,430 | $23.00 |
| Sep 16, 2026 | Mike Mensinger | Sale | 2,650 | $22.00 |
| Sep 16, 2026 | Mike Mensinger | Sale | 2,650 | $22.00 |
| Sep 16, 2026 | Mike Mensinger | Sale | 2,650 | $22.00 |
| Sep 16, 2026 | Mike Mensinger | Sale | 2,650 | $22.00 |
| Sep 16, 2026 | Mark Hopman | Sale | 30,779 | $20.13 |
| Sep 16, 2026 | Mark Hopman | Sale | 30,779 | $20.13 |
| Sep 16, 2026 | Mark Hopman | Sale | 30,779 | $20.13 |
| Sep 16, 2026 | Mark Hopman | Sale | 30,779 | $20.13 |
| Sep 14, 2026 | Mark Hopman | Sale | 775 | $15.52 |
| Sep 14, 2026 | Mark Hopman | Sale | 775 | $15.52 |
| Sep 14, 2026 | Mark Hopman | Sale | 775 | $15.52 |
BBNX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $100.25M | $-73.20M | -1.81 | $-50.92M |
| Dec 31, 2024 | $65.12M | $-54.76M | -8.60 | $-48.27M |
| Dec 31, 2023 | $11.99M | $-44.10M | -8.31 | $-32.45M |
Latest balance sheet: total assets $292.39M, total liabilities $36.02M, cash $44.32M (as of Jun 30, 2026).
BBNX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 29, 2026 | 8-K Item 2.02 (results) | $15.17 |
| Apr 21, 2026 | 8-K Item 2.02 (results) | $12.27 |
| Feb 17, 2026 | 8-K Item 2.02 (results) | $13.97 |
| Jan 8, 2026 | 8-K Item 2.02 (results) | $31.99 |
| Oct 28, 2025 | 8-K Item 2.02 (results) | $24.28 |
| Jul 29, 2025 | 8-K Item 2.02 (results) | $14.66 |
| May 6, 2025 | 8-K Item 2.02 (results) | $11.35 |
| Mar 25, 2025 | 8-K Item 2.02 (results) | $15.22 |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on BBNX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.